# Anti-Amyloid Therapies and ARIA - Highlighting the Pearls of the POC Tool with Dr. Christina Shenvi

Page: https://stenobird.com/podcast/acep-frontline-452279/anti-amyloid-therapies-and-aria-highlighting-the-pearls-of-the-poc-tool-with-dr-christina-shenvi
Text version: https://stenobird.com/podcast/acep-frontline-452279/anti-amyloid-therapies-and-aria-highlighting-the-pearls-of-the-poc-tool-with-dr-christina-shenvi.md
Podcast: [ACEP Frontline](https://stenobird.com/podcast/acep-frontline-452279)
Published: 2025-12-31T07:12:43+00:00
Episode link: https://acep-frontline.captivate.fm
Audio file: https://episodes.captivate.fm/episode/46b7a795-b606-407f-969b-5cf3acae5ba6.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/acep-frontline-452279/episodes/anti-amyloid-therapies-and-aria-highlighting-the-pearls-of-the-poc-tool-with-dr-christina-shenvi
Duration seconds: 1657

## Resource

In this episode, we get an update on Anti-Amyloid therapies and ARIA, along with the new POC tool to help physicians navigate these therapeutics and how they may impact patients in the emergency department. We talk with Dr. Christina Shenvi who introduced us to ARIA earlier in the year and now we have more evidence and a POC tool. Supported by Eli Lilly, USA

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/acep-frontline-452279/episodes/anti-amyloid-therapies-and-aria-highlighting-the-pearls-of-the-poc-tool-with-dr-christina-shenvi/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/acep-frontline-452279/anti-amyloid-therapies-and-aria-highlighting-the-pearls-of-the-poc-tool-with-dr-christina-shenvi.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.